<?xml version='1.0' encoding='utf-8'?>
<document xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" id="D.C. Law 16-37">
  <num type="law">16-37</num>
  <heading type="short">Prescription Drug Excessive Pricing Act of 2005</heading>
  <meta>
    <effective>2005-12-10</effective>
    <citations>
      <citation type="law" url="./docs/16-37.pdf">D.C. Law 16-37</citation>
      <citation type="register">52 DCR 9061</citation>
    </citations>
    <history url="http://lims.dccouncil.us/Legislation/B16-0114">
      <narrative>Law 16-37, the “Prescription Drug Excessive Pricing Act of 2005”, was introduced in Council and assigned Bill No. 16-114 which was referred to the Committee on Judiciary. The Bill was adopted on first and second readings on May 3, 2005, and July 6, 2005, respectively. Signed by the Mayor on October 4, 2005, it was assigned Act No. 16-171 and transmitted to both Houses of Congress for its review. D.C. Law 16-37 became effective on December 10, 2005.</narrative>
    </history>
  </meta>
</document>
